Deep Genomics sets up shop to marry deep learning and genomics

Deep Genomics has opened its doors. The University of Toronto spinout is working to explore the potential of applying deep learning to genomics, first as a way to improve genetic testing. The early focus on genetic testing is a way for Deep Genomics to get started quickly, but in the longer term the plan is to apply the approach to drug development and personalized medicine. "We envision a future where computers are trusted to predict the outcome of laboratory experiments and treatments, long before anyone picks up a test tube," Deep Genomics CEO Brendan Frey told Kurzweil Accelerating Intelligence. Article | More

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.